Gynecomastia in Multi-Drug Resistant Tuberculosis—Ethionamide the Villain
Excerpt
A 59-year-old married male, a known case of line probe assay-confirmed multidrug-resistant pulmonary tuberculosis was treated with kanamycin, levofloxacin, ethionamide, ethambutol, pyrazinamide and cycloserine for seven months [...]
Share and Cite
Deokar, K.; Shaikh, A.L.; Chawla, G. Gynecomastia in Multi-Drug Resistant Tuberculosis—Ethionamide the Villain. Adv. Respir. Med. 2020, 88, 162-163. https://doi.org/10.5603/ARM.2020.0093
Deokar K, Shaikh AL, Chawla G. Gynecomastia in Multi-Drug Resistant Tuberculosis—Ethionamide the Villain. Advances in Respiratory Medicine. 2020; 88(2):162-163. https://doi.org/10.5603/ARM.2020.0093
Chicago/Turabian StyleDeokar, Kunal, Abdul Latif Shaikh, and Gopal Chawla. 2020. "Gynecomastia in Multi-Drug Resistant Tuberculosis—Ethionamide the Villain" Advances in Respiratory Medicine 88, no. 2: 162-163. https://doi.org/10.5603/ARM.2020.0093
APA StyleDeokar, K., Shaikh, A. L., & Chawla, G. (2020). Gynecomastia in Multi-Drug Resistant Tuberculosis—Ethionamide the Villain. Advances in Respiratory Medicine, 88(2), 162-163. https://doi.org/10.5603/ARM.2020.0093